Lipopolysaccharides from Escherichia coli O111:B4, FITC conjugate

Cat. No.: XGB678

Lipopolysaccharides from Escherichia coli O111:B4, FITC conjugate

Synonym: LPS

  • MDL: MFCD00164401
  • NACRES: NA.25
Product Size
1 mg;10 mg
Price
Datasheet
MSDS
Properties
Biological Source
Escherichia coli (O111:B4)
Form
lyophilized powder
Purity
FITC conjugate
Solubility
H2O: soluble 4.90-5.10 mg/mL, faintly hazy to hazy, pale yellow to yellow
Applications
FITC-Lipopolysaccharides (FITC-LPS) may be used to evaluate, qualify and quantify lipopolysaccharides (LPS) removal reagents and procedures. FITC-LPS conjugate may be used for the detection of LPA binding proteins and motifs. Lipopolysaccharides (LPSs) are characteristic components of the cell wall of Gram-negative bacteria. LPS and its lipid A moiety stimulate cells of the innate immune system by the Toll-like receptor 4 (TLR4), a member of the Toll-like receptor protein family, which recognizes common pathogen-associated molecular-patterns (PAMPs).
Safety Information
Personal Protective Equipment
Eyeshields, Gloves, type N95 (US)
WGK Germany
WGK 3
Hazard Statements
H300
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0